---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-001536"
form_type: "8-K"
ticker: null
cik: "0001368620"
company_name: "Cann American Corp."
filed_at: "2023-03-16T23:59:59+00:00"
generated_at: "2026-06-18T00:19:19.714012+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Cann American completes acquisition of Prodigy Stem Cell; appoints founder as director

## Summary
- Entered binding LOI on Jan 30, 2023 to acquire Prodigy Stem Cell, LLC as wholly owned subsidiary.
- Acquisition completed on March 1, 2023; Prodigy becomes wholly owned subsidiary.
- Prodigy Stem Cell focuses on sales, marketing, and consulting for regenerative medicines.
- Peter Caruso, founder of Prodigy, appointed as director effective March 1, 2023.

## SEC filing metadata
- accession: 0001683168-23-001536
- form_type: 8-K
- cik: 0001368620
- company_name: Cann American Corp.
- filed_at: 2023-03-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 1.01, 2.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/0001683168-23-001536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/cann_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-001536
- JSON: https://secwatch.observer/filing/0001683168-23-001536.json
- Plain text: https://secwatch.observer/filing/0001683168-23-001536.txt

## Key facts
- Executive change
  Peter Caruso was appointed as Director at Cann American Corp..
  - Action: appointed
  - Role: Director
  source text: On March 1, 2023, the Company appointed Peter Caruso as a Director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/0001683168-23-001536-index.htm
- M&A Transactions
  Cann American Corp. completed an acquisition involving Prodigy Stem Cell, LLC (closed 2023-03-01).
  - Action: acquisition
  - Counterparty: Prodigy Stem Cell, LLC
  - Closing: 2023-03-01
  source text: On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell, LLC as a wholly owned subsidiary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/0001683168-23-001536-index.htm
- Material Agreements
  Cann American Corp. entered into Binding Letter of Intent with Prodigy Stem Cell, LLC (effective 2023-01-30).
  - Action: entry
  - Agreement: merger
  - Counterparty: Prodigy Stem Cell, LLC
  - Effective: 2023-01-30
  source text: Item 1.01 Entry into a Material Definitive Agreement. On January 30, 2023, the Company entered into a Binding Letter of Intent to acquire Prodigy Stem Cell, LLC as a wholly owned subsidiary of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/0001683168-23-001536-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.